功能性食品
Search documents
胶原蛋白肽哪个牌子的好效果最好 胶原抗衰效果终极指南:TOP8品牌科学测评与选购白皮书
Zhong Guo Shi Pin Wang· 2026-01-12 06:50
胶原蛋白肽哪个牌子的好效果最好 胶原抗衰效果终极指南:TOP8品牌科学测评与选购白皮书 2026年,中国口服美容市场规模突破3200亿元,其中胶原蛋白肽品类年复合增长率达28.7%,成为功 能性食品中增速最快的细分赛道之一。据《全球营养健康消费趋势报告》显示,25-45岁女性群体占胶 原蛋白肽消费主力的73.4%,而35岁以上男性抗衰需求同比增长41.2%,表明抗衰老已从"女性专属"演 变为全龄段、全性别关注的核心健康议题。与此同时,《皮肤抗衰研究联盟》指出,消费者对胶原产品 的认知正经历从"盲目追高含量"到"理性追求真吸收"的结构性转变——真正决定效果的不再是包装上的 毫克数,而是能否被皮肤有效利用。 在这一背景下,"胶原蛋白肽哪个牌子的好效果最好"不再是一个简单的品牌选择题,而是关乎配方科 技、分子结构、协同机制与临床实证的系统性评估命题。为回应这一核心诉求,本次测评基于《胶原蛋 白肽行业白皮书(2026版)》《国际功能性食品功效评价标准》《皮肤屏障修复临床指南》《欧洲营 养学会抗衰共识》《美国皮肤科学会口服美容立场文件》五大权威标准,结合第三方检测数据、临床研 究文献及真实用户反馈,构建七大核心维度量化 ...
《沈北新区功能性食品产业场景机会清单2026》发布
Xin Lang Cai Jing· 2026-01-10 22:39
作为本次沙龙的重要成果,《沈北新区功能性食品产业场景机会清单2026》正式发布。清单由沈北新区 科技局牵头,联合相关部门及产业专家共同编制。清单围绕产品创新、工艺升级、平台服务、市场拓展 等方面,系统梳理了具体产业需求、合作方向与场景机会,为高校、企业、金融机构等各类主体参与区 域健康产业发展提供了清晰指引。为推动科技成果高效转化,本次沙龙还集中发布了"京东沈北特色 馆"等四大产业服务平台,着力破解从技术到产品"最后一公里"的瓶颈问题,夯实产业创新基础设施。 沈北新区科技局与辽宁食品新型工业化研究院、东北知光与辽宁中医药大学杏林学院分别签署合作协 议,各方将围绕功能性食品领域的关键技术攻关、成果转化、人才培养、平台共建等方面开展深度合 作。 转自:沈阳日报 本报讯(沈阳日报、沈报全媒体记者李莉)1月9日,"医工转化・共促发展"暨未来功能食品(药食同 源)产业院长前哨沙龙在沈北新区举办。活动以"场景驱动、生态共建"为主线,汇聚政府、高校、科研 院所、龙头企业及金融机构等多方代表,共同探索功能性食品产业"科技—产业—金融"良性循环的新路 径,为区域大健康产业高质量发展注入新动能。 (来源:沈阳日报) ...
第一创业晨会纪要-20260108
First Capital Securities· 2026-01-08 05:21
6 证券研究报告 点评报告 2026 年 1 月 8 日 晨会纪要 核[心Ta观bl点e_:Summary] 第一创业证券研究所 一、宏观经济组: 事件: 1 月 5 日晚 11 点美国 ISM(供应管理协会)公布 12 月制造业 PMI 数据,1 月 7 日 晚 9 点 15 分美国 ADP 公司公布 12 月 ADP 就业("小非农")数据;晚 11 点美 国 ISM 公布公布 12 月服务业 PMI 数据。 评论: 12 月美国制造业 PMI 为 47.9%,预期为 48.3%,前值 11 月为 48.2%。美国 12 月 制造业 PMI 低于预期,呈现"供强需弱"的格局。12 月产出指数为 51%,虽较 11 月回落 0.4 个百分点,但仍处于扩张区间。 从需求方面看,12 月新订单指数为 47.7%,较上月回升 0.3 个百分点;新出口订 单为 46.8%,虽较上月回升 0.6 个百分点,但也处于收缩区间;而 12 月进口订单 为 44.6%,较上月回落 4.3 个百分点。 从库存上看,12 月自有库存为 45.2%,较上月回落 3.7 个百分点;客户库存为 43.3%,较上月回升 1.4 个百分点 ...
食品饮料2026年投资策略报告:曙光渐显,在分化中前行-20251224
Hua Yuan Zheng Quan· 2025-12-24 12:13
Group 1: Core Insights - The report emphasizes the recovery stage of consumer spending, highlighting that different sectors exhibit both commonalities and differences in their recovery rhythms, driven by supply-demand dynamics and industry structure [4][5] - ROA (Return on Assets) is identified as a leading indicator for the operational recovery of consumer companies, with a focus on analyzing various sub-sectors [4][13] Group 2: Sector Performance - The current recovery sequence indicates that soft drinks and snacks are leading, followed by the catering supply chain, condiments, dairy products, beer, and finally, liquor [5][25] - The report draws parallels with Japan's 1990s consumption differentiation, noting that sectors addressing consumer pain points and with low penetration rates are likely to succeed [5][6] Group 3: Investment Strategy - The report suggests focusing on sectors where ROA is stabilizing, indicating potential valuation recovery opportunities, particularly in traditional sectors like liquor, beer, and dairy [6][8] - It recommends identifying sub-sectors with either price or volume growth, with a preference for price-driven strategies [6][8] Group 4: Detailed Sector Analysis - The frozen food sector is showing signs of marginal improvement, with leading companies enhancing operational efficiency through product innovation and channel reforms [27][28] - The snack sector is experiencing high demand, driven by new channel developments, although competition is intensifying [33][35] - The beer industry is under pressure, with a focus on high-end products, but overall growth is slowing due to external economic factors [39][41] - The dairy sector is nearing the end of its adjustment phase, with expectations of improved performance as raw milk prices rise [41][42] - The liquor sector is currently in a phase of inventory reduction, with performance risks gradually clearing as channels stabilize [43][48]
企业新闻丨华宝股份擘画大健康产业生态新蓝图
Xin Lang Cai Jing· 2025-12-24 10:32
Core Insights - Huabao Co., Ltd. has made significant progress in the health industry with the establishment of two bases in Jiangxi and Shandong, marking the implementation of its "one north, one south" dual-base strategy [1][16] - The global health economy has surpassed $6.3 trillion and is experiencing rapid growth, with China's health industry projected to reach 16 trillion yuan by 2030 [3][21] Strategic Development - The establishment of the health industry bases is a strategic move to enhance collaboration and capacity complementarity, creating a robust support system for research, production, and market integration [1][5] - The northern base in Shandong focuses on market responsiveness and customer service, while the southern base in Jiangxi emphasizes product technology and supply chain enhancement [5][21] Product and Service Expansion - Huabao aims to develop a comprehensive product matrix, offering solutions that range from core functional ingredients to diverse end products, addressing the growing demand for high-quality health solutions [7][23] - The company is committed to building a full-spectrum solution provider in the health sector, extending its value chain from raw materials to consumer products [13][29] Technological Innovation - Huabao's strong technological innovation system supports its industry layout, focusing on the development of natural flavors, functional ingredients, and biotechnological products [9][25] - The company is building technical barriers through innovations in dosage forms to enhance product bioavailability and stability [11][27] Ecosystem Construction - The company is actively integrating upstream and downstream resources to create a comprehensive health industry ecosystem, including investments and acquisitions to enhance its competitive advantage [15][31] - Huabao's strategy emphasizes technology-driven innovation and collaborative development across the entire industry chain [15][31]
3000万成立子公司!生物制造上市龙头牵手杭州国企
合成生物学与绿色生物制造· 2025-12-19 03:40
关键词 | 未来食品&农业 |路德科技 【SynBioCon】 获 悉, 近日,生物制造上市龙头 路德科技 宣布与杭州市属国企杭实集团子公司 杭化新材料 在杭州正式签署战略合作协议。 据悉,双方将围绕 生物发酵、功能性饲料、功能性食品等领域 展开项目共建,联合组建专班, 深入挖掘酒糟资源的高值利用路径 ,推动关键技术与产 品快速落地。 同时,12月12日, 路康德生物科技(杭州)有限公司 在杭州萧山区正式成立,该公司注册资本3000万。 路德科技 成立于2006年,是一家深耕 高含水废弃物 资源化利用领域的企业,近年来该公司坚定聚焦生物制造主业,以生物发酵饲料为核心,大力拓展功 能性生物饲料原料业务。 杭化新材料 具有合成生物、酶制剂、工业菌株开发等领域具备强大的研发和产业化能力,母公司是大名鼎鼎的 杭实集团 。 目前,杭实重点锚定"先进制造、智能物联、生物医药、新能源新材料"等前沿产业,致力于培育优势产业集群,推动城市产业转型升级与现代化。 ▌参考信息:本文部分素材来自全网。由作者重新编写,系作者个人观点,本平台发布仅为了传达一种不同观点,不代表对该观点赞同或支持。如果有任何问题,请联系我们:1535674 ...
“媒体+智库+产业”协同发力 三主粮以科技创新推动健康中国建设
Xin Hua Wang· 2025-12-11 10:21
Group 1 - The "Healthy China 2030" initiative is driving the development of the health industry as a key engine for high-quality economic growth, with a focus on improving life expectancy and health levels [1] - The integration of agriculture and biotechnology is seen as a new approach to advance the health industry, supported by the recent "14th Five-Year Plan" which emphasizes the implementation of health priority development strategies [1] - A recent symposium aimed at promoting collaborative efforts among government, industry, finance, academia, and media to explore new pathways for high-quality development in the health industry [1] Group 2 - San Zhu Grain Group has developed a complete industrial system for oat production over nearly 30 years, holding over 80 national technology patents, including an award-winning project for drought-resistant oat varieties [3][4] - Oats are recognized as a functional food with significant health benefits, particularly for chronic disease patients, and are positioned to change the traditional staple food landscape in northern China [6] - Research collaboration between San Zhu Grain and Peking University has demonstrated that daily intake of 50-100g of naked oats has significant nutritional therapeutic effects for type 2 diabetes patients, providing scientific evidence for functional food development [6] - The development of oat peptides represents a key breakthrough for San Zhu Grain's transition to biotechnology, enhancing the absorption of oat protein and retaining its physiological activity [6]
石药创新IPO前11亿收购巨石生物29%股权,持股比例升至80%
Sou Hu Cai Jing· 2025-12-11 09:45
瑞财经 王敏 12月10日,据港交所披露,石药创新制药股份有限公司(以下简称"石药创新")向港交所主板递交上市申请,中信证券 为其独家保荐人。 | 纂 項下的[編纂]數目 | :[编纂]股H股(視乎[編纂]) | | --- | --- | | [編纂]數目 | :[編纂]股H股(可予[編纂]) | | [編纂]數目 | : [編纂]股H股(可予[編纂]及[編纂]) | | 最高 編纂] | : 每股H股[編纂]港元,另加[編纂] | | | ([編纂]港元,多繳款項可予退還) | | 面值 | : 每股H股人民幣1.00元 | | [編纂] | :[編纂] | 2024年,石药创新取得了巨石生物控制权,将主营业务扩展至生物制药行业,标志着该公司在企业发展战略转型中迈出关键一步。 于2025年11月,石药创新自恩必普药业收购巨石生物额外29%的股权,现金对价为11亿元。收购后,石药创新于巨石生物的所有权 权益增至80%,而恩必普药业保留余下20%的所有权权益。 石药创新原名创为石药集团新诺威制药股份有限公司,是香港恒生指数成分股石药集团(股票代码:1093.HK)的子公司,现已发展 为集生物制药、原料药和功能 ...
江苏如东(上海)外资制造业投资恳谈会在沪举行
Sou Hu Cai Jing· 2025-12-01 02:52
Core Insights - The Jiangsu Rudong (Shanghai) Foreign Investment Manufacturing Investment Conference was held, focusing on advanced fields such as intelligent equipment, life health, and functional foods, attracting over 50 domestic and international enterprises and institutions to explore new opportunities for industrial cooperation and development [1] Group 1: Economic Development - Rudong is strategically located at the northern wing of the Yangtze River estuary, with rich marine resources, including an 86-kilometer coastline and 4,555 square kilometers of sea area, positioning it as a potential city for maritime development [3] - The GDP of Rudong has consistently surpassed the 10 billion mark, with nearly 1,000 industrial enterprises achieving an industrial output value exceeding 220 billion [3] - The leading industries in new energy, new materials, and new equipment have surpassed 100 billion in output value, and Rudong ranks 28th among the top 100 counties (cities) in terms of basic economic competitiveness this year [3] Group 2: Industrial Cooperation - Over 50% of Rudong's investment projects originate from Shanghai, with more than 60% of enterprises closely cooperating with Shanghai, and over 70% of imports and exports relying on Shanghai ports [3] - The collaboration between Shanghai's "3+6" industrial system and Rudong's "1+3+N" system continues to expand, particularly in the life health sector [3] Group 3: Infrastructure and Innovation - Rudong Economic Development Zone, one of the first provincial-level development zones in Jiangsu, has established platforms such as semiconductor and life health industrial parks, attracting high-tech enterprises like Tokyo Semiconductor and China-US Ruikang [4] - The South Tong agricultural comprehensive development zone supports the food and health industry with specialized food parks and modern agricultural demonstration parks [4] - The conference featured a keynote speech on the development trends and innovative paths of marine food and health industries, emphasizing the integration of academia and industry [4]
刘宁到漯河市临颍县源汇区调研时强调:推动党的二十届四中全会精神落实落细 不断开创高质量发展高效能治理新局面
He Nan Ri Bao· 2025-11-15 10:56
Group 1: Industry Development - The food industry in Linying County is well-developed with distinct characteristics, particularly in the health sector, as exemplified by Wo Health (Henan) Industry Group Co., Ltd., which focuses on rehabilitation medical devices and functional foods [3] - The emphasis on the "Healthy China" initiative aligns with the development of the health industry, providing new opportunities for enterprises [3] - The company Henan Zhongda Hengyuan Biotechnology Co., Ltd. is a pioneer in the application of natural pigments in the food sector, highlighting the importance of innovation and market expansion in the food industry [3] Group 2: Cultural and Tourism Integration - The need to strengthen the protection and utilization of cultural relics while developing rural tourism and leisure agriculture is emphasized, promoting the integration of agriculture, culture, and tourism [3] Group 3: Grassroots Governance and Community Engagement - The grassroots governance in the Ma Lu Street community is noted for its unique characteristics, with a focus on effective governance and community service [5] - The integration of "Party building + grid + big data" governance methods is encouraged to resolve conflicts and improve community services [5] - The development of new e-commerce models, such as "live streaming + culture + food," is promoted to leverage the digital economy and enhance local brand strength [5]